NCT06578611

Brief Summary

As China's society ages faster, the number of elderly patients undergoing spinal fusion surgery will gradually increase. Since elderly patients are at higher risk of postoperative complications than younger patients, minimizing complications after spinal fusion becomes a priority in postoperative rehabilitation. The purpose of this prospective cohort study is to develop an enhanced recovery after surgery program including individualized perioperative smoking cessation strategies in Chinese elderly undergoing spinal fusion.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
20mo left

Started Sep 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Sep 2024Dec 2027

First Submitted

Initial submission to the registry

August 27, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 29, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

August 29, 2024

Status Verified

August 1, 2024

Enrollment Period

2.2 years

First QC Date

August 27, 2024

Last Update Submit

August 28, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of any complications

    Any major or minor complications occurs during this study will be reported.

    From the date of surgery until 6 months after surgery or the date of death from any cause, whichever come first.

Secondary Outcomes (4)

  • Length of hospital stay

    From the date of admission until the date of discharge or the date of death from any cause, whichever come first, assessed up to 6 months.

  • Prevalence of postoperative pain

    From the date of surgery until 6 months after surgery or the date of death from any cause, whichever come first.

  • Prevalence of pain-related disability

    From the date of surgery until 6 months after surgery or the date of death from any cause, whichever come first.

  • Level of quality of life

    From the date of surgery until 6 months after surgery or the date of death from any cause, whichever come first.

Study Arms (3)

Non-smokers

Patients who did not smoke at recruitment and during follow-up.

Continuous smokers

Patients who smoked at recruitment and during follow-up.

Combination Product: Enhanced recovery after surgery

Smoking quitters

Patients who smoked at recruitment but quitted during follow-up.

Combination Product: Enhanced recovery after surgery

Interventions

Recommended pre-, intra-, and post-operative care interventions in the enhanced recovery after surgery.

Continuous smokersSmoking quitters

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged 65 years old or more undergoing spinal fusion.

You may qualify if:

  • Patients aged 65 years old or more;
  • Patients who plan to undergo spinal fusion with ERAS program;
  • Patients who agreed to participate in this study.

You may not qualify if:

  • Patients who cannot understand the study content or have difficulty communicating;
  • Patients with a history of spinal fusion surgery;
  • Patients with spinal fractures, spinal tumor, or spinal infections;
  • Patients with congenital spinal deformity;
  • Patients who were unable to complete at least 6 months of follow-up;
  • Patients with incomplete clinical information.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Second Hospital of Shandong University

Jinan, Shandong, 250033, China

Location

Biospecimen

Blood samples will be collected after admission for assessment of biomarkers.

MeSH Terms

Interventions

Enhanced Recovery After Surgery

Intervention Hierarchy (Ancestors)

Perioperative CareSurgical Procedures, Operative

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2024

First Posted

August 29, 2024

Study Start

September 1, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

August 29, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations